UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.794

Sortiert nach

Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction

British journal of cancer, 2011-09, Vol.105 (6), p.760-765

2011

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal Cancer

Clinical cancer research, 2018-01, Vol.24 (2), p.316-325

2018

Link zum Volltext

Verfügbarkeit prüfen

CT colonography: value of scanning in both the supine and prone positions

American journal of roentgenology (1976), 1999-03, Vol.172 (3), p.595

1999

Link zum Volltext

Verfügbarkeit prüfen

Responses and durability of clinical benefit in pancreatic ductal adenocarcinoma (PDAC) patients treated with pegilodecakin (AM0010) in combination with 5-FU/LV and oxaliplatin (FOLFOX)

Annals of oncology, 2018-10, Vol.29, p.viii406-viii406

2018

Link zum Volltext

Verfügbarkeit prüfen

Immunohistochemical evaluation of K- ras, p53, and HER-2/ neu expression in hyperplastic, dysplastic, and carcinomatous lesions of the pancreas: Evidence for multistep carcinogenesis

Human pathology, 1999-02, Vol.30 (2), p.123-129

1999

Link zum Volltext

Verfügbarkeit prüfen

Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases

ESMO open, 2023-04, Vol.8 (2), p.100884-100884, Article 100884

2023

Link zum Volltext

Verfügbarkeit prüfen

Low-dose trimetrexate glucuronate and protracted 5-fluorouracil infusion in previously untreated patients with advanced pancreatic cancer

Annals of oncology, 2002-04, Vol.13 (4), p.582-588

2002

Link zum Volltext

Verfügbarkeit prüfen

PEAK: A Randomized, Multicenter Phase II Study of Panitumumab Plus Modified Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) or Bevacizumab Plus mFOLFOX6 in Patients With Previously Untreated, Unresectable, Wild-Type KRAS Exon 2 Metastatic Colorectal Cancer

Journal of clinical oncology, 2014-07, Vol.32 (21), p.2240-2247

2014

Link zum Volltext

Verfügbarkeit prüfen

Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials Program

Journal of clinical oncology, 2014-09, Vol.32 (27), p.2975-2982

2014

Link zum Volltext

Verfügbarkeit prüfen

Thermal properties of MoSi2 and SiC whisker-reinforced MoSi2

Journal of materials science, 1992-05, Vol.27 (10), p.2749-2752

1992

Link zum Volltext

Verfügbarkeit prüfen

Processing and mechanical properties of niobium-reinforced MoSi2 composites

Materials science & engineering. A, Structural materials : properties, microstructure and processing, 1991-10, Vol.144 (1-2), p.277-285

1991

Link zum Volltext

Verfügbarkeit prüfen

Interdependencia cleptocrática: Caso de estudio El Salvador

Desafios (Bogotá, Colombia), 2016-08, Vol.28 (2), p.65-111

Gómez-Hecht, J. R, Juan Ricardo

2016

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant therapy for gastric cancer: a reality at last

Current gastroenterology reports, 2000-12, Vol.2 (6), p.478-481

Hecht, J R

2000

Link zum Volltext

Verfügbarkeit prüfen

Prolonged nausea and vomiting after high dose chemotherapy and autologous peripheral stem cell transplantation in the treatment of high risk breast carcinoma

Cancer, 1997-05, Vol.79 (9), p.1698-1702

1997

Link zum Volltext

Verfügbarkeit prüfen

Male breast cancer

American journal of clinical pathology, 1994-10, Vol.102 (4 Suppl 1), p.S25-S30

1994

Link zum Volltext

Verfügbarkeit prüfen

Gastrointestinal toxicity or irinotecan

Oncology (Williston Park, N.Y.), 1998-08, Vol.12 (8 Suppl 6), p.72

Hecht, J R

1998

Link zum Volltext

Verfügbarkeit prüfen

Dietary fat and colon cancer

Advances in experimental medicine and biology, 1996, Vol.399, p.157

Hecht, J R

1996

Link zum Volltext

Verfügbarkeit prüfen

Clostridium difficile colitis secondary to intravenous vancomycin

Digestive diseases and sciences, 1989, Vol.34 (1), p.148-149

1989

Link zum Volltext

Verfügbarkeit prüfen

SPIRITT: A multicenter, open-label, randomized, phase II clinical trial evaluating safety and efficacy of FOLFIRI with either panitumumab or bevacizumab as second-line treatment in patients with metastatic colorectal cancer (mCRC) with wild-type KRAS tumors

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.TPS195-TPS195

2010

Link zum Volltext

Verfügbarkeit prüfen

Development of continuous-fiber-reinforced MoSi2-base composites

Materials science & engineering. A, Structural materials : properties, microstructure and processing, 1992-07, Vol.155 (1-2), p.19-31

1992

Link zum Volltext

Verfügbarkeit prüfen

Progression-free survival in intention to treat populations versus total KRAS populations in patients treated for metastatic colorectal cancer: A pooled review

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.4054-4054

2009

Link zum Volltext

Verfügbarkeit prüfen

Polymerase chain reaction-based K-ras mutation detection of pancreatic adenocarcinoma in routine cytology smears

American journal of clinical pathology, 1996-03, Vol.105 (3), p.321-326

1996

Link zum Volltext

Verfügbarkeit prüfen

Results from the LOGiC Trial

MD conference express, 2013-07, Vol.13 (6), p.20-20

2013

Link zum Volltext

Verfügbarkeit prüfen

PLX4032 in metastatic colorectal cancer patients with mutant BRAF tumors

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.3534-3534

2010

Link zum Volltext

Verfügbarkeit prüfen

Pegfilgrastim in colorectal cancer (CRC) patients (pts) receiving every-two-week (Q2W) chemotherapy (CT): Long-term results from a phase II, randomized, controlled study

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.4072-4072

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.794

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.466)
Mit Volltextzugriff
(1.580)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.047)
Life Sciences & Biomedicine
(715)
Humans
(584)
Female
(348)
Biological And Medical Sciences
(343)
Male
(325)
Physical Sciences
(275)
Medical Sciences
(243)
Animals
(188)
Adult
(180)
Middle Aged
(146)
Physics
(126)
Biochemistry & Molecular Biology
(111)
Fundamental And Applied Biological Sciences. Psychology
(111)
Exact Sciences And Technology
(104)
Technology
(104)
Aged
(97)
Mice
(92)
Genetics & Heredity
(87)
Chemistry
(85)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)
... seit 90 Tagen
(14)

Menü

Weitere Dienste

Einstellungen

Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction

A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal Cancer

CT colonography: value of scanning in both the supine and prone positions

Responses and durability of clinical benefit in pancreatic ductal adenocarcinoma (PDAC) patients treated with pegilodecakin (AM0010) in combination with 5-FU/LV and oxaliplatin (FOLFOX)

Immunohistochemical evaluation of K- ras, p53, and HER-2/ neu expression in hyperplastic, dysplastic, and carcinomatous lesions of the pancreas: Evidence for multistep carcinogenesis

Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases

Low-dose trimetrexate glucuronate and protracted 5-fluorouracil infusion in previously untreated patients with advanced pancreatic cancer

PEAK: A Randomized, Multicenter Phase II Study of Panitumumab Plus Modified Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) or Bevacizumab Plus mFOLFOX6 in Patients With Previously Untreated, Unresectable, Wild-Type KRAS Exon 2 Metastatic Colorectal Cancer

Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials Program

Thermal properties of MoSi2 and SiC whisker-reinforced MoSi2

Processing and mechanical properties of niobium-reinforced MoSi2 composites

Interdependencia cleptocrática: Caso de estudio El Salvador

Adjuvant therapy for gastric cancer: a reality at last

Prolonged nausea and vomiting after high dose chemotherapy and autologous peripheral stem cell transplantation in the treatment of high risk breast carcinoma

Male breast cancer

Gastrointestinal toxicity or irinotecan

Dietary fat and colon cancer

Clostridium difficile colitis secondary to intravenous vancomycin

SPIRITT: A multicenter, open-label, randomized, phase II clinical trial evaluating safety and efficacy of FOLFIRI with either panitumumab or bevacizumab as second-line treatment in patients with metastatic colorectal cancer (mCRC) with wild-type KRAS tumors

Development of continuous-fiber-reinforced MoSi2-base composites

Progression-free survival in intention to treat populations versus total KRAS populations in patients treated for metastatic colorectal cancer: A pooled review

Polymerase chain reaction-based K-ras mutation detection of pancreatic adenocarcinoma in routine cytology smears

Results from the LOGiC Trial

PLX4032 in metastatic colorectal cancer patients with mutant BRAF tumors

Pegfilgrastim in colorectal cancer (CRC) patients (pts) receiving every-two-week (Q2W) chemotherapy (CT): Long-term results from a phase II, randomized, controlled study

Suchergebnisse filtern